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ABSTRACT 
Background 
Occupational latex exposure in health care workers (HCWs) has been linked to an 
array of atopic conditions, including asthma, urticaria, and conjunctivitis. 
Although studies have explored sensitization rates at varying exposure levels, 
there has been little longitudinal research on the reported outcomes after latex 
exposure. We investigated the relationship between between latex exposure, as 
determined by years worked as a HCW, and subsequent atopic disease outcomes 
as determined from medical claims data. The aims of this retrospective cohort 
study are to match previously identified healthcare employees with potential latex 
exposure from the Duke Health and Safety Surveillance System (DHSSS) to 
subsequent health outcomes potentially related to latex allergies and symptoms; 
identify the risk factors associated with these outcomes, and describe the extent 
and type of these problems. Based on the results, suggestions for future research 
and possible surveillance strategies will be proposed. 
Methods 
Using a comprehensive integrated surveillance system for health care workers in a 
tertiary health care system, a cohort of2,119 HCWs were evaluated through a 
questionnaire for potential for latex exposure, a history of latex use and latex 
allergy, or symptoms likely to be latex allergy. Data was linked to medical claims 
for a two- year period (2002 and 2003) and de-identified individuals with less 
then 24 months of insurance for the two- year period were excluded from 
analysis. Using the International Classification of Diseases, Ninth Revision (ICD-
9, seven categories of atopic health outcomes (asthma, lungs, conjunctivitis, 
dermatitis, rhinitis, skin, and urticaria) were derived by grouping diseases 
potentially related to latex exposure according to the literature. Atopic outcome 
prevalence rates were calculated for strata defined by age, race, gender, years as a 
health care worker, years of latex glove use, and occupation. Logistic regression 
was used to relate these risk factors to the atopic outcomes. 
Results 
In all seven outcomes categories, the prevalence among female employees was 
significantly higher than males. Blacks had a higher prevalence than Whites and 
Other (summary variable containing Asian/Pacific Islander/American Indian) for 
Asthma, Lung, and Urticaria medical claims; however the employees in the Other 
race/ethnicity category had a higher prevalence of conjunctivitis, dermatitis, 
rhinitis, and skin. Asthma was the only atopic outcome with a statistically 
significant relationship to the exposure variable (years as a HCW). Logistic 
regression results extended those from the stratified analysis. Seven sets of 
multivariate models were created, each using one of the latex related medical 
claim categories as the dependent variable. Females were found to have 3.12 
(1.45-6.70) greater adjusted odds than males of having had asthma across all 
models. No significant associations were found in the fully adjusted model for 
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age, race, years worked as a HCW, and occupational group. Having worked less 
than 23 years as a health care worker was found to be significantly associated 
with lung disease. No significant associations were observed between the rhinitis, 
conjunctivitis, skin, or urticaria when adjusting for age, gender, race/ethnicity, 
duration as HCW, and occupational group. 
Discussion 
Overall, the studies results show little evidence that risk factors for latex allergy 
result in significantly increased prevalence of atopic outcomes as determined for 
medical claims. These results emphasize the need for future investigations 
examining the relationship between actual reactivity rates and latex exposure. 
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INTRODUCTION 
The National Institute of Occupational Safety and Health (NIOSH) has identified 
health care workers (HCWs) as a special population at risk of occupational 
disease and injury. Hospitals are complex workplaces and job related tasks have 
the potential to expose medical staff to many hazards. Natural rubber latex (NRL) 
has become an important occupational health concern among HCWs, who for 
protection against infectious and other noxious agents, often are required to wear 
latex gloves when working. 
Studies suggest that latex sensitization may be mediated by direct contact with 
latex gloves and by aerolized antigens. 1' 3 Latex allergies fall into either type 1 
(immediate reaction) or type IV categories (the delayed reaction) and exposure 
has been associated with short and long term atopic health complications such as 
asthma. 4' 6 Sensitized workers who continue to be exposed to latex antigens 
demonstrate increased risk for related health complaints, and increased sensitivity 
to other related antigens. 7' 8 The only known treatment for the reduction of latex 
sensitization is through cessation of exposure. 9' 13 
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Occupational latex allergy began to be studied in health care workers with greater 
frequency soon after the implementation of the Occupational Safety and Health 
Administration bloodbome pathogen standard in 1992. Epidemiological studies 
have reported prevalence estimates varying from 5% to 17%. 14-19 Traditional 
studies have investigated NRL sensitization via various in vitro methods or via 
self reported symptoms with objective confirmation. 16 The limitations of these 
previous studies are found in the lack of standardized testing methods, and 
focusing on type 1 reaction outcomes resulting in inconsistent conclusions. 
Although studies have explored sensitization rates at varying exposure levels, 
there has been little longitudinal research on the reported outcomes to latex. 15 Our 
study investigates this rarely studied area of latex exposure, as determined by 
years as a HCW, and subsequent atopic disease outcomes. 
The aims of this retrospective cohort study are to match previously identified 
healthcare employees with potential latex exposure from the Duke Health and 
Safety Surveillance System (DHSSS) to subsequent health outcomes potentially 
related to latex allergies and symptoms; identify the risk factors that are 
associated with these outcomes, and describe the extent and type of these 
problems. Based on these findings, suggestions for future research and possible 
surveillance strategies will be proposed. 
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MATERIALS AND METHODS 
Duke Health and Safety Surveillance System (DHSSS) 
A Duke University School of Medicine research team has developed and 
implemented a comprehensive surveillance system within the Duke University 
Health System (DUHS) that tracks occupational exposures and stressors, injuries 
and illnesses, as well as their causes and consequences, in a large, well-defined, 
population of health care workers. 20 This has been accomplished through a 
combination of population-based (i.e. employment records, worker compensation 
injury and illness records, work culture surveys, and occupational exposure data) 
and case based data. Liukage across data sets allows for individual level data 
analyses. 
Latex Surveillance Program 
The study cohort was assembled from data relating to Duke University Health 
System employees evaluated through a questionnaire for potential for latex 
exposure, a history of latex use and latex allergy, or symptoms likely to be latex 
allergy (Figure I). Employees with potential for latex exposure completed a 
baseline survey at the time of pre-placement evaluations or routine Purified 
Protein Derivative (PPD) testing. Furthermore, a subset of these individuals, 
namely those with a history oflatex allergy were identified and clinically 
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evaluated for the development of new symptoms related to latex or worsening of 
latex allergy. The latex exposure and latex allergy data was linked with human 
resources data extracted from the larger Duke University Health System 
comprehensive surveillance database (which has been in place for three years 
[2001-2004] with surveillance of a cohort of over I 0,000 health care workers 
employed by the health system) and health insurance claims data to assess health 
outcomes from the questionnaire, the chart review, and health claims potentially 
related to latex exposure. 
Descriptive Analysis 
Data management was performed using Microsoft Access. Data was linked to 
medical claims for a two- year period (2002-2003) and de-identified individuals 
with less then 24 months of insurance for the two- year period were excluded 
from analysis. Using the International Classification of Diseases, Ninth Revision 
(ICD-9, seven categories of atopic health outcomes (asthma, lungs, conjunctivitis, 
dermatitis, rhinitis, skin, and urticaria) were derived by grouping diseases 
potentially related to latex exposure according to the literature. 21 -22 (Appendix A) 
Some of these groupings are very specific while others are more general. More 
than one medical claim by an individual in the same ICD-9 group was only 
counted once, allowing us to estimate in a 24-month period prevalence for these 
outcomes (i.e. for these analyses, an employee with 24 months of insurance could 
contribute a maximum of one event in each of the seven health outcome 
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categories in a 24 months period regardless of how many identical medical claims 
where filed in the time period). The claim events were stratified by age, race, 
gender, years as a healthcare worker, years oflatex glove use, and occupational 
group in order to calculate stratum-specific period prevalence of the seven atopic 
outcomes. The cut points for age were chosen in an effort to equally distribute the 
number of employees in each group. Occupational groups were originally created 
from DUBS payment categories. From these original groups, smaller subgroups 
were produced from Human Resources data to make the size of each group large 
enough and the occupational group variable more manageable. An 'Other' 
occupational category comprised smaller occupational categories that were 
identified as having little latex glove exposure through the survey. 
Multivariate Analysis 
Logistic regression models for each health claim category were developed to 
further explore the relationship between the risk factors for and atopic outcomes 
while controlling for potential confounders. Independent variables of interest 
included age, gender, race, years ofDUHS employment, and job category. We 
began building the models by constructing bivariate models for each of the 
parameters used for stratified analysis. Reference cell coding was used to generate 
appropriate internal comparisons for odds ratios. The reference cell for the 
occupational variable was defined as a latex exposure low risk group of job 
descriptions (from the original43 job descriptions). Following the bivariate 
8 
regression modeling, variables for inclusion in the multivariate model were 
selected. The criterion for inclusion was a statistical significance (Type III 
likelihood ratio p-value<0.25) for initial inclusion of parameters into the model. 
This level was chosen to ensure that covariates included in the final model to 
address the possibility that a collection of variables, each with a risk to related 
medical claims, might be an important predictor of risk and not too highly 
correlated with another variable (i.e. years as HCW and years of glove use). 
For the logistic regression analysis, predictor variables found to be important were 
introduced in groups (chunks). Three final models are presented for each of the 
two data sets (1) demographic variables, (2) model 1 + exposure variable (number 
ofyears as aHCW), and (3) model2 +occupational groups (exposure variable). 
The differences in the number of subjects between models 2 and 3 are caused by 
lack of claims in some occupational categories. 
The data was analyzed using Stata (release# 8 software Stata Corp., College 
Station, TX) to calculate risk estimates and 95% confidence intervals (Cis). The 
project was approved by the Duke University Human Subject Institutional Review 
Board. 
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RESULTS 
Population Demographics 
Demographic characteristics of health care workers included in these analyses are 
shown in Table I. A total of2,119 workers were employed in jobs with potential 
latex exposure and had uninterrupted insurance coverage in 2002 and 2003. Of 
these workers, 73.6% were female and 26.4% male. The predominant race/ethnic 
group was White (60.9%) followed by Black (35.4%), Asian/Pacific Islander 
(3.07%), Hispanic (0.57%) and American Indian (0.09%). The mean age at the 
start of follow-up was 44.8 years, and, on average, these workers had worked at 
DUHS for 13.5 years. A wide range of occupations were represented with 
inpatient nurses being the predominant group (19.6%), followed by office 
support-medical (7.9%), administrative and ambulatory care nurses (7.4%), and 
housekeeping staff/supervisors (6.5%). Table 1 also describes latex glove 
exposure and previously described risk factors for latex allergy. Latex glove use 
was reported by 68.5% of employees. On average employees had worn latex 
gloves 14.3 years. 
Latex Exposure risk and Medical Claims-Stratified Analysis 
The prevalence ofHCW with one or more claims for specific disease in two- year 
follow-up period (2002 and 2003) are shown in Table II. Prevalence of atopic 
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outcomes are stratified by gender, race/ethnicity, age, years of latex glove use, 
duration as a health care worker, and job category. In all seven outcome 
categories, the prevalence among female employees was significantly higher than 
males. Blacks had a higher prevalence of than Whites and Other (summary 
variable containing Asian/Pacific Islander/American Indian) for Asthma, Lung, 
and Urticaria; however the employees in the Other race/ethnicity category had a 
higher prevalence of conjunctivitis, dermatitis, rhinitis, and skin. Rhinitis, skin 
and urticaria were most prevalent in employees 35 years of age or less, with 
employees greater than 55 years of age having the highest prevalence of asthma, 
lung, and dermatitis. Employees 35-44 years of age had the highest conjunctivitis 
prevalence. Asthma was the only atopic outcome with a relationship to exposure 
variable (years as a HCW). In the asthma, lung, and rhinitis categories the highest 
prevalence occurred in the 15 to 22 year age range. 
Stratified prevalence was calculated for job categories. Among occupation 
categories with four or more cases oflatex allergy, asthma had a higher 
prevalence among physician's assistants, clinical lab technicians, phlebotomists, 
ambulatory nurses, and inpatient nurses. There was a high prevalence oflung 
disease in physician assistants, inpatient nurses, inpatient nurses-managers, 
phlebotomists, and among those in nursing care service. For conjunctivitis, 
physician/occupational therapists, clinical lab technicians, nursing care service, 
inpatient nurses, and medical office support personnel were observed to have the 
highest prevalence. Other clinical or professional personnel, clinical lab 
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technicians, radiology/imaging technicians, phlebotomist, and inpatient nurses 
recorded the highest prevalence of dermatitis. Respiratory diseases were highest 
in physician assistants, physical! occupational therapists, radiology/imaging 
technologists, medical office support personnel, and administrative nurses and 
ambulatory care personnel. Office support was the occupational grouping with the 
highest prevalence of skin diseases, followed by phlebotomists, administrative 
nurses and ambulatory care personnel, other clinical and professional personnel, 
and faculty. There was a low prevalence of urticaria across all groups, with the 
medical office support classification having the highest at 2.4%. 
Multivariate Analyses 
In bivariate models, age, gender, race/ethnicity, duration as a HCW, and 
occupational group were found to be predictors of atopic, latex related, health 
outcomes (Table III). Bivariate analysis demonstrated unadjusted statistical 
significance for the variables gender, years of latex glove use, and numbers of 
years as a HCW for the asthma outcome. The exposure variable, number of years 
as a HCW, was significant for the lung disease outcome. The occupational 
categories all other clinical/professionals and clinical lab technicians/supervision 
showed unadjusted significance for dermatitis. 
Seven sets of these multivariate models were created, each using one of the latex 
related, atopic disease categories (as determined from medical claims) as the 
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dependent variable (Table IV). Females were found to have 3.12 (1.45-6.70) 
greater adjusted odds than males of having had asthma across all models. No 
significant associations were found in the fully adjusted model (Model 3, Table 
IV) for age, race, duration as a HCW, and occupational group. Having worked 
less than 23 years as a health care worker was found to be significantly associated 
with lung disease. Employees who have worked 7-14 years as a healthcare worker 
had 2.10 greater odds (1.19-3.73) of having a lung related medical claim after 
adjusting for all other variables. Both female gender and the occupational 
categories; all other clinical/ professional and clinical lab technician; were 
significantly associated with dermatitis. No significant associations were 
observed between rhinitis, conjunctivitis, skin, or urticaria when adjusting for age, 
gender, race/ethnicity, duration as HCW, and occupational group. 
DISCUSSION AND CONCLUSION 
Summary of Results 
The current study integrated human resources data and medical insurance claims 
to examine the potential risk factors associated with latex related atopic outcomes. 
We found that non-white race may be a risk factor for latex-related medical 
outcomes, significantly in asthma. Asthma showed a dose response of increased 
prevalence with the variable 'years as a HCW', but the relationship loses strength 
in multivariate analysis. With the exception of dermatitis, there was no significant 
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finding between the occupational categories and seven potentially latex related 
atopic outcomes. 
The lack of significant results in consistent with the literature. When measuring 
latex-specific IgE, Kibby and Aid (1997) found no significant difference in latex 
between reactors and non-reactors based on the length of service among hospital 
employees. 21 Only a few studies have evaluated association of occupation and 
latex-related symptoms and those that have vary in their outcomes. Liss eta! 
(1997) found a high prevalence oflatex sensitization among laboratory worker 
(16.9%) and among nurses and physicians (13.3%) in a study of 1351 hospital 
HCW s. 23 Both Twjanmaa and Smedley et a!. reported that operating room staff 
were at increased risk of sensitization compared to examination and laboratory 
staff or outpatient nurses. 2• 24 In contrast, Grzybowski et a!. found operating room 
nurses to be at the lowest risk group among all nursing specialties in their study. 25 
In studies of hospital employees, Hunt (1995) and Tmjanmaa (1987) found that 
latex sensitivity three to five times greater among nurses and physicians than 
among personnel with no patient contact. 2• 26 No studies have compared the 
prevalence oflatex allergies among HCWs and other working populations. 
Prior studies have highlighted the difficulties in NRL allergy research. A similar 
study by Me Call et a!. (2003) found no statistical evidence of an increased 
prevalence of potential NRL-related conditions among HCW s compared to non-
medical occupations. 15 Additionally, the study used National Heath Interview 
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Survey results from 1983-1994, and found no temporal trend of increasing 
potential NRL-related conditions over time after introduction of universal 
precautions (i.e. correlate for increased glove use). 
Strengths and Limitations 
The Duke Health and Safety Surveillance System integrates information from a 
number of existing data systems, allowing for comprehensive surveillance of 
adverse occupational events. For the current analysis of latex exposure and 
subsequent health claims, the DHSSS extended a traditional case-based reporting 
system (e.g. worker's compensation) with data from an occupational latex allergy 
survey to allow for follow-up health care workers and potentially latex related 
atopic outcomes. While using symptoms as a means of assessing reactivity has 
been used in other studies as a viable method to estimated occupational disease, 
most of these studies focus on worker's compensation claims analysis. 27-32 This 
study was unique in its focus on using medical claims as a more objective 
measure of latex reactivity to help identify risk factors. 
Study limitations stem from the use of self-report data. Using self-reported data 
did result in high percentage of individuals with missing data for the variable 
"years of latex gloves glove use" making it difficult to use as in analysis. Based 
on current studies there is no clear relationship between the risk of sensitization 
and duration of exposure to latex gloves. The deficit points toward an area of 
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further research. Additionally, these types of data could result in the estimates of 
potential latex related data being less specific than studies that involve in vivo 
testing for allergic reactions. However, unlike previous research the focus of this 
study was on the potential atopic reactions to latex versus the actual sensitization 
of the employee. Therefore, it is hard to make a direct comparison between these 
results and those of prior research. 
The use of medical claims as an indicator of potential latex reactions in the 
absence of specific test for latex reactivity is an additional limitation of the study. 
It is possible that many of reactions indicated by the seven medical claims 
categories measured among HCW s could be due to factors other than latex 
exposure and the burden of disease in this population could be overestimated or 
underestimated. 
A fourth limitation is that those employed in medical occupations who suffered 
from latex related atopic conditions may have left the medical field or entered an 
occupation not requiring contact with latex. The sample was restricted to those 
who had complete insurance coverage during the two years of the data analysis. 
This potentially biases the study towards the healthy, and shifts estimated odds 
ratios downward. The variable, "years as a health care worker" is limited to years 
of employment at DUHS, and thus information about previous employment was 
not available for analysis. 
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The cost associated with latex related medical claims should be a focus of 
additional research. Some studies have looked at the medical costs associated with 
latex use and switching to vinyl gloves, and a study by Phillips et a!. suggests that 
when only glove costs are considered, switching to a latex -safe approach was 
more expensive for medical facilities (tertiary care hospital, community hospital, 
outpatient internal medicine clinic) than continued latex glove use; yet the authors 
acknowledge that all costs that would favor the latex-safe conversion were not 
included such as patient-related liability, or temporary disability. The costs 
associated with job loss may be impossible to measure. The authors also 
advocated a switch to powder-free gloves in non-surgical areas as a way to 
reduced antigens in the environment. 
Conclusions 
Overall, the studies results show little statistical evidence that risk factors for latex 
allergy result in significantly higher prevalence of atopic outcomes as indicated 
by medical claims. The strengths of this study are its longitudinal nature and the 
enumeration of a population of over 2,000 HCW s with potential latex exposure 
using integrated human resources data. These results emphasize the need for 
future investigations examining the relationship between actual reactivity rates 
and latex exposure. Future research of this nature may include a longer time frame 
and more objective assessment of both latex exposure and relevant more specific 
outcomes. 
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The results of our study, which was done in close collaboration with the Duke 
Employee Occupational Health Service, will help serve as aid for enhancing and 
evaluating ongoing prevention efforts. Guidelines for latex allergy prevention are 
already in place in the Duke University Health System. Employees are 
encouraged to assess their own risk based on duration of latex glove use and 
medical history. HCW s should make educated decisions about when and what 
kind of gloves to use. DUHS encourages those anticipating contact with blood 
and body fluids for a short period of time to choose synthetic (non-latex) gloves 
and low-protein, powder-free latex gloves for times when extended wear is 
needed. Future implementation of an on-going surveillance procedure may be 
warranted for follow-up assessment for those jobs or work locations identified as 
high risk. 
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Table 1: Demographic Characteristics ofDUHS Health Care Workers 
Cohort with potential for latex exposure 
Variable . . ·. 
Mean Age at Start of Follow-up (Std. Dev) 44.8(9.7) 
Age, Number(%) 
<25-34 382 (18.0) 
35-44 636(30.0) 
45-54 733(34.6) 
55-65+ 368 (17.4) 
Gender, Number(%) 
Female 1559 (73.6) 
Male 560 (26.4) 
Race/Ethnicity, Number(%) 
Asian 65(3.1) 
Black 750(35.4) 
Hispanic 12(0.57) 
American Indian 2(0.09) 
White 1290(60.9) 
Mean years of latex glove use (Std. Dev) 14.31(9.2) 
Years Latex Glove Use, Number(%) 
<=9 years 504(34.7) 
10-19 years 513(35.3) 
. >=20 years 435(30.0) 
Mean Years as Health Care Worker (HCW) at start 13.5(9.95) 
of follow-up (Std. Dev) 
Number of years as HCW, Number(%) 
<6 year 620(30.6) 
7-14 years 557(27.5) 
15-22 years 480(23.7) 
>23 years 367(18.1) 
Occupational Description', Number(%) 
All Other~Clinical/Prof 59(2.8) 
Clinical Lab Tech/Supv 79(3.7) 
Faculty 119(5.6) 
House Staff 19(0.90) 
Housekeeping Staff/Supv 138(6.5) 
Nursing Inpatient 416(19.6) 
Nursing Inpatient- Admin!Manager 36(1.7) 
Nursing, Admin & Ambul Care 157(7.4) 
Office Support - Medical 167(7.9) 
Phlebotomist/Tech!Supv 14(0.66) 
1 Employees were originally grouped into 43 occupational groups. 
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Physical-OccupTherapy Tech/Supv 35(1.7) 
Physician's Assistant/ Associate 19(0.90) 
Radiology & Imaging Tech/Staff/Supv 68(3.2) 
Respiratory Care Tech/Supv 17(0.80) 
Service, Nursing Care 64(3.0) 
Other 712(33.6) 
. 
. . 
Physician Diagnosis* 
Hay Fever 37 (17.5) 
Sinusitis 532(25.1) 
Chronic Bronchitis 121(5.7) 
Asthma 240(11.3) 
Eczema 146(6.9) 
Latex Allergy 80(3.8) 
Allergies* 
Medication 639(30.3) 
Food 200(9.4) 
Other 700(33.0) 
* The number of people that gave vahd responses (m1ssmg data are excluded 
from analysis) 
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Table ll: Number (Prevalence) of Health Workers (2002-2003) with one 
more claims for specific atopic diseases in two year follow-up period for 
b su )grou s 
Variable ·· N Asthma Lungs . Rhinitis ·. 
. .· .. ·. .. . 
Age 
<25-34 382 12(3.14) 17(4.45) 28(7.32) 
35-44 636 13(2.04) 31(4.87) 31(4.87) 
45-54 733 37(5.05) 50(6.82) 45(6.13) 
55-65+ 368 23(6.25) 30(8.15) 14(3.80) 
Gender 
Female 1559 76(4.87) 98(6.29) 93(5.97) 
Male 560 9(1.61) 30(5.36) 25(4.46) 
Race/Ethnicity 
Black 750 31(4.13) 55(7.33) 47(6.27) 
Other 79 2(2.53) 5(6.33) 5(6.33) 
White 1290 52(4.03) 68(5.27) 66(5.12) 
Years Latex Glove 
Use 
<=9 years 504 12(2.38) 22(4.37) 30(5.95) 
10-19 years 513 27(5.26) 36(7.02) 23(4.48) 
>=20 years 435 19(4.37) 29(6.67) 25(5.75) 
Number of years as 
HCW 
<6 year 620 15(2.42) 22(3.55) 34(5.48) 
7-14 years 557 22(3.95) 40(7.18) 29(5.21) 
15-22 years 480 27(5.63) 35(7.29) 29(6.04) 
>23 years 367 19(5.18) 25(6.81) 22(5.99) 
Occupational 
Description' 
All Other-Clinical/Prof 59 3(5.08) 1(1.69) 3(5.08) 
Clinical Lab Tech/Supv 79 6(7.59) 3(3.80) 5(6.33) 
Faculty 119 4(3.36) 6(5.04) 2(1.68) 
House Staff 19 0 0 0 
Housekeeping Staf£1'Supv 138 2(1.45) 9(6.52) 8(5.80) 
Nursing Inpatient 416 19(4.57) 23(5.53) 18(4.33) 
Nursing Inpatient- 36 2(5.56) 3(8.33) 1(2.78) Admin/Manager 
Nursing, Admin & Ambul 157 10(6.37) 13(8.28) 10(6.37) Care 
Office Support -Medical 167 8(4.79) 11(6.59) 12(7.19) 
Phlebotomist!Tech/Supv 14 1(7.14) 1(7.14) 1(7.14) 
Physical-OccupTherapy 35 1(2.86) 1(2.86) 3(8.57) Tech/Supv 
Physician's 19 2(10.53) 2(10.53) 3(15.79) Assistant/ Associate 
Radiology & Imaging 68 1(1.47) 1(1.47) 5(7.35) 
2 Employees were originally grouped into 43 occupational groups. 
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Tech/Staf£'Suov 
Respiratory Care 17 0 1(5.88) 1(5.88) Tech/Supv 
Service, Nursing Care 64 1 (1.56) 5(7.81) 2(3.13) 
Other 712 25(3.51) 48(6.74) 44(6.18) 
I. 
r-
------
~ 
.. · .. · . 
I .· . 
. 
. · .·· . . . . 
Physician Diagnosis* 
Hay Fever 370 36(9.73) 27(7.30) 51(13.78) 
Sinusitis 532 46(8.65) 44(8.27) 71(13.34) 
Chronic Bronchitis 121 24(19.20) 20(16.53) 14(11.57) 
Asthma 240 70(29.17) 30(12.50) 26(10.83) 
Eczema 146 8(5.48) 15(10.27) 16(10.96) 
Latex Allergy 80 9(11.25) 5(6.25) 6(7.50) 
Allergies* 
Medication 639 53(8.29) 56(8.76) 52(8.14) 
Food 200 21(10.50) 9(4.50) 17(8.50) 
Other 700 61(8.71) 52(7.43) 84(12.0) 
* The number of people that gave valid responses (m1ssmg data are excluded 
from analysis) 
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Table II (cont): Number (Prevalence) of Health Workers (2002-2003) with 
one more claims for specific atopic diseases in two year follow-up period for 
subgroups 
VanaJ;ne , ......•..... ::::::;: INn : .. · <.;cni}uU:9f I1)91'ffiaHtis · 
Age 
<25-34 382 7 (1.83) 18 (4.71) 
35-44 636 18(2.83) 28(4.40) 
45-54 733 16(2.18) 46(6.28) 
55-65+ 368 6(1.63) 28(7.61) 
Gender 
Female 1559 36(2.30) 105(6.73) 
Male 560 11(1.96) 15(2.68) 
Race/Ethnicity 
Black 750 17(2.26) 44(5.86) 
Other 79 2(2.53) 6(7.59) 
White 1290 28(2.17) 70(5.43) 
Years Latex Glove Use 
<-9 years 504 8(1.59) 23(4.56) 
10-19 years 513 12(2.34) 32(6.24) 
>-20 years 435 8(1.84) 24(5.52) 
Number of years as 
HCW 
<6 year 620 12(1.94) 31(5.00) 
7-14 years 557 17(3.05) 33(5.92) 
15-22 years 480 9(0.21) 21(4.38) 
>23 years 367 7(1.91) 29(7.90) 
Occupational 
Description' 
All Other-Clinical/Prof 59 1 (1.69) 9(15.25) 
Clinical Lab Tech/Supv 79 4(5.06) 11(13.92) 
Faculty 119 0 1(0.84) 
House Staff 19 0 0 
Housekeeping Staffi'Supv 138 1(0.72) 4(2.90) 
Nursing Inpatient 416 13(3.13) 29(6.97) 
Nursing Inpatient- 36 1(2.78) 2(5.56) Admin/Manager 
Nursing, Admin & Ambul 157 1(0.64) 10(6.37) Care 
Office Support -Medical 167 5(2.99) 10(5.99) 
Phlebotomist/Tech/Supv 14 0 1(7.14) 
Physical-OccupTherapy 35 2(5.71) 2(5.71) Tech/Supv 
Physician's 19 0 0 Assistant! Associate 
Radiology & Imaging 68 0 5(7.35) T ech/Staf£'Supv 
3 Employees were originally grouped into 43 occupational groups. 
Respiratory Care 17 0 1(5.88) Tech/Sll]J_v 
Service, Nursing Care 64 2(3.13) 1(1.56) 
Other 712 17(2.39) 34(4.78) 
········>> ( :>.:>:· [[;; r•··: .>>t:•c:·• b• > .·:; :;:;;. 
Physician Diagnosis* 
Hay Fever 370 12(3.24) 27(7.30) 
Sinusitis 532 13(2.44) 43(8.08) 
Chronic Bronchitis 121 4(3.31) 12(9.92) 
Asthma 240 8(3.33) 16(6.67) 
Eczema 146 4(2.74) 26(17.81) 
Latex Allergy 80 3(3.75) 9(11.25) 
Allergies* 
Medication 639 13(2.03) 56(8.76) 
Food 200 5(2.50) 10(5.0) 
Other 700 17(2.43) 48(6.86) 
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Table II (cont): Number (Prevalence) of Health Workers (2002-2003) with 
oue more claims for specific atopic diseases in two year follow-up period for 
... 
ouu,;•uupo ~ 
:<;' .,...... :;; < :; . r:;'>; 
Age 
<25-34 382 21(5.50) '; (1.83) 
35-44 636 25(3.93) 4(0.62) 
45-54 733 30(4.09) 9(1.22) 
55-65+ 368 16(4.35) ±Q.09) 
Female 1559 75(4.81) 20(1.28) 
Male 560 17(3.04) 4(0.71) 
R"ee/F.: ry 
Black 750 37(4.93) 1 0(1.33) 
Other 79 5(6.33) 1 ).27) 
White 1290 50(3.88) 31 '0.23) 
Years Latex Glove Use 
<~9 years 504 22(4.37) 6(1.19) 
10-19 years 513 16(3.12) 5(0.97) 
>~20 years 435 22(5.06) 5(1.15) 
Number u1 years as 
HCW 
<6 year 620 31(5.00) 7(1.13) 
7-14 years 557 23(4.13) 8(1.44) 
15-22 years 480 19(3.96) 2(0.42) 
>23 years 367 1fi(4 ifi) 3(0.82) 
.4 
All r 59 3(5.08) 1(1.69) 
Clinical Lab 
-y 79 2(2.53) 1(1.27) 
Faculty 119 5(4.20) 1(0.84) 
House Staff 19 0 0 
-y 138 3(2.17) 2(1.45) 
"ursmg 416 18(4.33) 6(1.44) 
N':,sing 36 0 0 
"' Admin & A~~~~ 157 9(5.73) 1(0.64) 
Office Support - M, · 167 12(7.19) 4(2.40) 
:t/Tech/Supv 14 1(7.14) 0 
nccnpTherapy 35 0 0 
Physician's 19 0 0 Assistant/Associate 
1& [m,"inP 68 2(2.94) 1(1.47) 
4 Employees were originally grouped into 43 occupational groups. 
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Respiratory Care 17 0 0 Tech/Suev 
Service, Nursing Care 64 1 (1.56) 0 
Other 712 36(5.06) 7(0.98) 
' ,,, ,' ,,;' ::: ,">,,';, ,' '" ">:>:,.,.,, L '':': •: I ''\ < '•>;;, 
Physician Diagnosis* 
Hay Fever 370 13(3.51) 4(1.08) 
Sinusitis 532 26(4.89) 6(1.13) 
Chronic Bronchitis 121 5(4.13) 3(2.48) 
Asthma 240 11(4.58) 3(1.25) 
Eczema 146 14(9.59) 2(1.37) 
Latex Allergy 80 5(6.25) 3(3.75) 
Allergies* 
Medication 639 28(4.38) 1 0(1.56) 
Food 200 14(7.0) 2(1.0) 
Other 700 31(4.43) 11(1.57) 
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Table III: Predictors of specific atopic diseases (as recorded through medical 
claims) bivariate odds ratio (95% CI) 
Variable Asthma ·. L)lllgs Rhinitis 
. 
. 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.81 0.89 1.03 
(0.28-2.34) (0.39-2.07) (0.46-2.32) 
45-54 2.58 1.04 2.10 
(0.54-12.4) (0.28-3.79) (0.55-7.96) 
55-65+ 4.07 1.02 2.01 
(0.43-38.1) (0.16-6.52) (0.28-14.38) 
Gender 
Female 3.14 Ll9 1.36 
(1.56-6.30) (0.78-1.80) (0.863-2.13) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 0.62 1.21 1.25 
(0.15- 2.59) (0.48-3.10) (0.49-3.20) 
Black 1.03 1.42 1.24 
(0.65- 1.62) (0.98-2.05) (0.84-1.82) 
White 1.00 1.00 1.00 
Years Latex Glove 
Use 
<-9 years 1.00 1.00 1.00 
I 0-19 years 2.28 1.65 0.74 
(L14-4.55) (0.96-2.85) (0.42-1.30) 
>=20 years 1.8 1.56 0.96 
7(0.90-3.90) (0.89-2.77) (0.56-1.66) 
Number of years as 
HCW 
<6 year 1.00 1.00 1.00 
7-14 years 1.66 2.10 0.95 
(0.85-3.23) (1.23-3.59) (0.57-1.58) 
15-22 years 2.40 2.14 Ll1 
(1.26-4.57) (1.24-3.70) (0.67-1.85) 
>23 years 2.20 1.99 LIO 
(LI0-4.39) (1.10-3.58) (0.63-1.91) 
Physician Diagnosis 
Hay Fever 4.51 1.29 4.52 
(2.74 -7.39) (0.83-2.01) (3.04-6.73) 
Sinusitis 4.15 1.65 530 
(2.63-6.54) (U2-2.42) (3.58-7 .86) 
Chronic Bronchitis 8.54 3.46 2.55 
(5.06-14.43) (2.06-5.82) (1.41-4.62) 
Asthma 55.87 2.59 2.61 
(30.28-103.09) (1.67-4.00) (1.64-4.16) 
Eczema 1.70 1.96 2.58 
(0.80-3.62) (U 1-3.46) (1.47-4.54) 
Latex Allergy 3.81 1.06 1.54 
(1.82-7.98) (0.42-2.68) (0.64-3.62) 
Allergies 
Medication 4.21 1.92 1.92 
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(2.66-6.66) (1.33-2.77) (1.31-2.80) 
Food 3.60 0.72 1.74 
(2.14-6.07) (0.36-1.44) (1.02-2.99) 
Other 6.06 1.39 6.24 
(3.66-10.05) (0.96-2.01) ( 4.04-9.61) 
Occupational 
Description 
All Other- 1.47 0.24 0.81 
Clinical/Prof (0.43-5.03) (0.03-1.76) (0.24-2.70) 
Clinical Lab 2.26 0.55 1.03 
Tech/Supv (0.90-5.69) (0.17-1.80) (0.39-2.67) 
Faculty 0.96 0.73 0.26 
(0.33-2.80) (0.31-1.76) (0.06-1.09) 
House Staff -
- -
Housekeeping 0.40 0.97 0.93 
Staf£'Supv (0.09-1.73) (0.46-2.02) (0.43-2.03) 
Nursing Inpatient 1.32 0.81 0.69 
(0.72-2.42) (0.48-1.35) (0.39-1.20) 
Nursing Inpatient- 1.62 1.26 0.43 
Admin/Manager (0.37-7.11) (0.37-4.25) (0.06-3.24) 
Nursing, Admin & 1.87 1.25 1.03 
Ambul Care (0.88-3.98) (0.66-2.37) (0.51-2.10) 
Office Support - 1.38 0.98 1.18 
Medical (0.61-3.12) (0.50-1.92) (0.61-2.28) 
Phlebotomist/Tech/Su 2.11 1.06 1.17 
pv (0.27-16.80) (0.14-8.31) (0.15-9.13) 
Physical- 0.81 0.41 1.42 OccupTherapy (0.11-6.14) (0.05-3.04) (0.42-4.83) Tech/Supv 
Physician's 3.232941 1.63 2.85 
Assistant! Associate (0.71-14.76) (0.37-7.25) (0.80-10.14) 
Radiology & Imaging 0.41 0.21 1.20 
Tech/Staf£'Supv (0.05-3.07) (0.03-1.52) (0.46-3.15) 
Respiratory Care 0.86 0.95 
Tech/SujlV - (0.11-6.66) (0.12-7.32) 
Service, Nursing Care 0.44 1.172316 0.49 (0.06-3.27) (0.45-3.06) (0.12-2.07) 
Other 1.00 1.00 1.00 
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Table III (cont.): Predictors of specific atopic diseases (as recorded through 
medical claims) bivariate odds ratio (9So/, CI) 0 
variable. :cc · ~-• .. C<.m}unct .•.· D~roiatitis 
Aoe 
<25-34 1.00 1.00 
35-44 3.93 2.10 
(1.05-14.70) (0.31-14.16) 
45-54 7.59 1.58 
(0.88- (0.42-5.98) 
65.56) 
55-65+ 14.04 1.01 
(0.62- (0.43-2.36) 
319.31) 
Gender 
Female 1.17 (0.60- 2.62 
2.33) (1.51-4.54) 
Male 1.00 1.00 
Race/Ethnicitv 
Other 1.17 1.43 
(0.27-5.01) (0.60-3.41) 
Black 1.05 1.09 
(0.57-1.92) (0.74-1.60) 
White 1.00 1.00 
Years Latex Glove Use 
<-9 years 1.00 1.00 
10-19 years 1.49 1.39 
(0.60-3.66) (0.80-2.41) 
>=20 years 1.56 1.22 
(0.89-2.77) (0.68-2.20) 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 1.60 1.20 
(0.75-3.37) (0.72-1.98) 
15-22 years 0.97 0.87 
(0.40-2.32) (0.49-1.53) 
>23 years 0.99 1.63 
(0.38-2.53) (0.97-2.75) 
Phvsician Dia!!nosis 
Hay Fever 1.66 1.43 
(0.85-3.25) (0.92-2.24) 
Sinusitis 1.21 1.72 
(0.63-2.32) (1.17-2.54) 
Chronic Bronchitis !.58 1.98 
(0.55-4.48) (1.06-3.73) 
Asthma 1.62 1.28 
(0.75-3.53) (0.74-2.21) 
Eczema 1.24 4.43 
(0.44-3.51) (2.75-7.14) 
Latex Allergy 1.76 2.33 
(0.53-5.82) (1.13-4.79) 
Alleroies 
Medication 0.87 2.11 
(0.46-1.68) (1.45-3.07) 
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Food 1.25 0.85 
(0.48-3.21) (0.44-1.66) 
Other 1.18 1.33 
(0.64-2.17) (0.91-1.94) 
Occupational 
Description 
All Other-Clinical/Prof 0.70 3.59 
(0.09-5.39) (1.63-7.90) 
Clinical Lab Tecb/Supv 2.18 3.23 
(0.72-6.65) (1.56-6.65) 
Faculty - 0.17 
(0.02-1.25) 
House Staff - -
Housekeeping 0.30 0.60 
Staf£'Supv (0.04-2.26) (0.21-1.71) 
Nursing Inpatient 1.32 1.49 
(0.63-2.74) (0.90-2.49) 
Nursing Inpatient- 1.17 1.17 
Admin/Manager (0.15-9.03) (0.27-5.09) 
Nursing. Admin & 0.26 1.36 
Ambul Care (0.03-1.98) (0.66-2.81) 
Office Support - 1.26 1.27 
Medical (0.46-3.47) (0.61-2.63) 
Phlebotomist/Tecb/Supv - 1.53 (0.19-12.07) 
Physical-OccupTherapy 2.48 1.21 
Tecb/Supv (0.55-11.17) (0.28-5.25) 
Physician's - -
Assistant/ Associate 
Radiology & Imaging - 1.58 
Tecb/Staff7Suov (0.60-4.19) 
Respiratory Care - 1.25 
Tecb/Supv (0.16-9.68) 
Service, Nursing Care 1.32 0.32 (0.30-5.84) (0.04-2.35) 
Other 1.00 1.00 
34 
>=20 years 
Number of years as 
HCW 
35 
Other 1.10 1.65 
(0.70-172) (0.73-3.70) 
Occupational 
Description 
All Other-ClinicaVProf 100 1.74 
(0.30-3.37) (0.21-14.36) 
Clinical Lab T ech/Supv 0.49 129 
(0.12-2.07) (0.16-10.63) 
Faculty 0.82 0.85 
(0.32-2.14) (0.10-7.00) 
House Staff 
- -
Housekeeping 0.42 1.48 
Staffi'Supv (0.13-1.37) (0.30-7.21) 
Nursing Inpatient 0.85 147 
(0.48-152) (0.49-4.42) 
Nursing Inpatient- - -
Admin/Manager 
Nursing, Admin & 1.14 0.65 
Ambul Care (0.54-2.42) (0.08-5.29) 
Office Support - 1.45 2.47 
Medical (0.74-2.86) (0.72-8.54) 
Phlebotomist/Tech/Supv 144 -(0.18-11.35) 
Physica1-0ccupTherapy - -
Teclt/Supv 
Physician's - -
Assistant/ Associate 
Radiology & Imaging 0.57 150 
T eclt/Staff/Supv (0.13-2.42) (0.18-12.40) 
Respiratory Care - -
Teclt/Supv 
Service, Nursing Care 0.30 -(0.04-2.21) 
Other 100 100 
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Table IV: Predictors of Specific atopic disease (as recorded through medical 
I . ) d. t d dd f (95o/t CI) c atms a I JUS e 0 s ra 10 0 
·. ASTHMA 
.. · ·.·... .·· ...... •· 
• 
Variable ·. Modell Model2 Model3 
·.· I • . 
N- 2024 2024 1977 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.66 0.47 0.48 
(0.30-1.46) (0.20-1.11) (0.20-1.14) 
45-54 1.56 1.08 1.08 
(0.80-3.05) (0.49-2.39) (0.48-2.41) 
55-65+ 2.18 1.52 1.62 
(1.07-4.47) (0.64-3.60) (0.68-3.90) 
Gender 
Female 3.47 3.49 3.12 
(1.66-7.26) (1.67- 7.30) (1.45-6.70) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 0.76 0.86 0.84 
(0.18-3.21) (0.20-3.71) (0.19-3.66) 
Black 1.04 1.08 1.50 
(0.65-1.65) (0.67-1.74) (0.87-2.60) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7~14 years 1.50 1.57 
(0.65-3.47) (0.76-3.26) 
15-22 years 2.27 2.07 
(I. 06-4. 86) (0.96-4.49) 
>23 years 1.50 1.33 
(0.65-3.47) (0.57- 3.15) 
Occupational 
Description 
All Other- 1.40 
Clinical/Prof (0.40-4.91) 
Clinical Lab 2.04 
Tech/Supv (0.78-5.38) 
Faculty 1.49 
(0.49-4.54) 
House Staff -
Housekeeping 0.34 
Staff!Supv (0.08-1.52) 
Nursing Inpatient 1.27 
(0.66-2.43) 
Nursing Inpatient- 1.70 
Admin/Manager (0.37-7.77) 
Nursing, Admin & 1.51 
Ambul Care (0.68-3.35) 
Office Support- 1.06 
Medical (0.46-2.47) 
Phlebotomist/Tech/ -
37 
Supv 
Physical- 1.04 
OccupTherapy (0.13-8.29) 
Tecb/Supv 
Physician1S 4.74 
Assistant/ Associate (0.98-22.92) 
Radiology & Irnagiug 0.49 
Tecb/Staff/Supv (0.06-3.77) 
Respiratory Care -
Tecb/Supv 
Service, Nursing Care 0.42 (0.05-3.25) 
Ofher 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
medical claims) adjusted odds ratio (95% CI) 
. 
·•· 
. •. 
LUNG . ·. 
. 
.· .. . · . · .. 
Variable Modell ·· Model2 . Mode13. • 
·. 
N- 2024 2024 1845 
Age 
<25-34 1.00 1.00 1.00 
35-44 1.08 0.79 1.22 
(0.59-1.99) (0.41-1.52) (0.58-2.56) 
45-54 1.52 1.08 1.08 
(0.86-2.68) (0.56-2.09) (0.56-2.09) 
55-65+ 1.73 1.23 1.22 
(0.92-3.26) (0.59-2.57) (0.58-2.56) 
Gender 
Female 1.33 1.35 1.39 
(0.85-2.07) (0.86-2.11) (0.86-2.23) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.38 1.63 1.64 
(0.54-3.56) (0.62-4.26) (0.62-4.33) 
Black 1.46 1.50 1.45 
(1.00-2.13) (1.02-2.21) (0.91-2.30) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 2.15 2.10 
(1.21-3.80) (1.19-3.73) 
15-22 years 2.12 2.05 
(1.14-3.97) (1.09-3.85) 
>23 years 1.61 1.56 
(0.79-3.25) (0.76-3.18) 
Occupational 
Description 
All Other- 0.26 
Clinical/Prof (0.03-1.93) 
Clinical Lab 0.53 
Tecb/Supv (0.16-1.78) 
Faculty 1.01 
(0.41-2.49) 
House Staff -
Housekeeping 0.87 
Staff/Supv (0.40-1.89) 
Nursing Inpatient 0.90 
(0.52-1.57) 
Nursing Inpatient- 0.94 
Admin!Manager (0.21-4.15) 
Nursing, Admin & 1.17 
Ambul Care (0.58-2.34) 
Office Support- 0.93 
Medical (0.46-1.90) 
Phlebotomist/Tech/ 1.02 
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Supv (0.13-8.19) 
Physical- 0.56 OccupTherapy (0.07-4.30) Tech/Supv 
Physician1s 1.98 
Assistant/ Associate (0.43-9.09) 
Radiology & Imaging 0.26 
Tech/StafflSupv (0.04-1.95) 
Respiratory Care 1.12 
Tech/Supv (0.14-8.91) 
Service, Nursing Care 
1.21 
(0.45-3.29) 
Other 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
d' I I . ) d' t d dd f (95o/. CI) me 1ca c aims a use 0 s ra 10 0 
·. 
... 
• ••••• 
.·· CONJUNCTIVITIS 
.· 
. . . . ·. 
.· 
Vmiable Modell Model2 · Model3 
. 
N- 2024 2024 1775 
Age 
<25-34 1.00 1.00 1.00 
35-44 1.82 1.78 1.89 
(0.72-4.63) (0.67-4.77) (0.70-5.09) 
45-54 1.42 1.45 1.50 
(0.55-3.66) (0.51-4.16) (0.52-4.34) 
55-65+ 0.91 0.93 1.00 
(0.27-3.01) (0.25-3.49) (0.26-3.80) 
Gender 
Female 1.28 1.29 1.01 
(0.63-2.60) (0.63-2.62) (0.48-2.13) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.17 1.19 1.14 
(0.27-5.07) (0.27-5.24) (0.25-5.16) 
Black 1.14 1.17 1.32 
(0.61- 2.11) (0.62-2.19) (0.63-2.77) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 1.50 1.40 
(0.68-3.30) (0.63-3.09) 
15-22 years 0.88 0.80 
(0.34-2.26) (0.31-2.09) 
>23 years 1.03 0.95 
(0.34-3.09) (0.31-2.92) 
Occupational 
Description 
All Other- 0.82 
Clinical!Prof (0.10-6.43) 
Clinical Lab 2.35 
Tech/Supv (0.72-7.67) 
Faculty -
House Staff -
Housekeeping 0.37 
StafflSupv (0.03-2.12) 
Nursing Inpatient 1.53 
(0.16-3.44) 
Nursing Inpatient- 1.32 
Admin!Manager (0.16-10.69) 
Nursing, Admin & 0.32 
Ambul Care (0.04-2.55) 
Office Support- 1.34 
Medical (0.46-3.89) 
Phlebotomist/Tech/ -
Supv 
41 
Physica!OccupTherap 2.88 
vTech/Supv (0.60-13.92) 
Physician1s -
Assistant/ Associate 
Radiology & Imaging -
Tech!Staf£1Supv 
Respiratory Care -
Tech/Supv 
Service, Nursing Care 1.25 (0.27-5.90) 
Other 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
medical claims) adjusted odds ratio (95% CI) 
· ... 
. · .. · 
DERMATITIS 
. · ... 
.. 
Variable ... Modell····· Model2 Model3 
- . 
. 
N- 2024 2024 1927 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.94 0.98 0.98 
(0.51-1.73) (0.51-1.86) (0.51-1.88) 
45-54 1.28 1.25 1.17 
(0.73-2.27) (0.65-2.41) (0.60-2.26) 
55-65+ 1.58 1.45 1.47 
(0.84-2.95) (0.69-3.05) (0.70-3.12) 
Gender 
Female 2.47 2.48 2.00 
(1.42-4.30) (1.43-4.32) (1.12-3.57) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.30 1.32 1.36 
(0.51-3.36) (0.51-3.44) (0.51-3.62) 
Black 1.02 0.97 1.33 
(0.68-1.52) (0.64-1.47) (0.83-2.11) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 1.15 1.05 
(0.67-1.98) (0.61-1.80) 
15-22 years 0.79 0.69 
(0.42-1.49) (0.36-1.31) 
>23 years 1.33 1.18 
(0.69-2.55) (0.61-2.29) 
Occupational 
Description 
All Other- 3.12 
Clinical/Prof (1.33-7.31) 
Clinical Lab 3.45 
Tech/Supv (1.60-7.43) 
Faculty 0.22 
(0.03-1.61) 
House Staff -
Housekeeping 0.54 
Staff/Supv (0.18-1.61) 
Nursing Inpatient 1.47 
(0.89-2.56) 
Nursing Inpatient- 1.23 
Admin!Manager (0.27-5.47) 
Nursing, Admin & 1.33 
Ambul Care (0.62-2.85) 
Office Support - 1.10 
Medical (0.52-2.34) 
Phlebotomist/Tech/ 1.33 
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Supv (0.17-10.76) 
Physica!OccupTherap 1.55 
yTech/Supv (0.34-6.95) 
Physician1s 
-Assistant! Associate 
Radiology & Imaging 1.83 
T ech/Staf£1Supv (0.68-4.97) 
Respiratory Care 2.39 
Tech/Supv (0.29-19.42) 
Service, Nursing Care -
Other 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
me d" I I . ) d" t d dd f (95o/. CI) Ica c mrns a use 0 s ra 10 0 
. ·
· . .. 
RHINITIS 
. 
. 
Variable . Mod.ell .· Model2 Model3 
. . 
N- 2024 2024 2005 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.67 0.57 0.57 
(0.39-1.14) (0.32-1.03) (0.31-1.04) 
45-54 0.83 0.64 0.63 
(0.50-1.37) (0.34-1.18) (0.34-1.17) 
55-65+ 0.51 0.37 0.38 
(0.26-1.00) (0.17-0.83) (0.17-0.84) 
Gender 
Female 0.70 1.43 1.45 
(0.44-1.12) (0.90-2.29) (0.89-2.38) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.26 1.40 1.68 
(0.49-3.25) (0.54-3.64) (0.63-4.46) 
Black 1.21 1.17 1.14 
(0.81-1.80) (0.78-1.76) (0.71-1.82) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 1.18 Ll1 
(0.68-2.03) (0.64-1.92) 
15-22 years 1.52 1.40 
(0.83-2.80) (0.76-2.59) 
>23 years !.58 1.46 
(0.78-3.20) (0.72-2.96) 
Occupational 
Description 
All Other- 0.88 
Clinical/Prof (0.26-2.99) 
Clinical Lab 1.02 
Tech/Supv (0.38- 2.72) 
Faculty 0.29 
(0.07-1.23) 
House Staff -
Housekeeping 0.85 
Staff/Supv (0.36-2.01) 
Nursing Inpatient 0.67 
(0.37-1.23) 
Nursing Inpatient- 0.46 
Admin/Manager (0.06-3.52) 
Nursing, Admin & 0.98 
Ambul Care (0.47-2.07) 
Office Support- Ll3 
Medical (0.56-2.25) 
Phlebotomist/Tech/ LIS 
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Supv (0.14-9.22) 
Physical- 1.49 
OccupTherapy (0.42-5.23) 
Tech/Supv 
Physician's 3.08 
Assistant/ Associate (0.84-11.32) 
Radiology & Imaging 1.24 
Tech/Staff/Supv (0.47-3.30) 
Respiratory Care 1.27 
Tech/Supv (0.16-10.18) 
Service, Nmsing Care 0.50 (0.11-2.16) 
Other 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
me d" . I I . ) d" t d dd f (95°/c CI) 1ca c aims a use 0 s ra 10 0 
SKIN 
Variable Modell Model2 Model3 
• 
·. . 
N- 2024 2024 1904 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.73 0.77 0.82 
(0.40- 1.34) (0.40-1.48) (0.43-1.58) 
45-54 0.76 0.81 0.85 
(0.42-1.36) (0.41-1.61) (0.42-1.71) 
55-65+ 0.82 0.88 0.89 
(0.41-1.63) (0.39-2.00) (0.39- 2.02) 
Gender 
Female 1.67 1.67 1.64 
(0.96-2.89) (0.96-2.89) (0.92-2.92) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.73 1.67 1.75 
(0.66-4.49) (0.64-4.41) (0.65-4.69) 
Black 1.28 1.28 1.26 
(0.82-2.00) (0.82-2.01) (0.76-2.10) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7-14 years 0.90 0.88 
(0.50-1.63) (0.49-1.58) 
15-22 years 0.89 0.84 
(0.45-1.73) (0.43-1.66) 
>23 years 0.90 0.81 
(0.42-1.94) (0.37-1.76) 
Occupational 
Description 
All Other- 1.04 
ClinicaVProf (0.30-3.54) 
Clinical Lab 0.47 
Tech/Supv (0.11-2.02) 
Faculty 0.83 
(0.31-2.23) 
House Staff -
Housekeeping 0.38 
Staff/Supv (0.11-1.29) 
Nursing Inpatient 0.78 
(0.42- 1.44) 
Nursing Inpatient-
-Admin/Manager 
Nursing, Admin & 0.96 
Ambu1 Care (0.42-2.17) 
Office Support- 1.17 
Medical (0.57-2.41) 
Phlebotomist/Tech/ 1.20 
47 
Supv (0.15-9.64) 
Physical-
OccupTherapy -
Tech/Supv 
Physician's 
-Assistant/ Associate 
Radiology & Imaging 0.55 
Tech/Staf£/Supv (0.13-2.35) 
Respiratory Care 
-
Tech/Supv 
Service, Nursing Care 0.26 (0.03-2.00) 
Other 1.00 
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Table IV (cont.): Predictors of Specific atopic disease (as recorded through 
me d" I I . ) d" t d dd f (95o/c CI) 1ca c a1ms a use 0 s ra 10 0 
.. .. 
. .. 
·.· 
·. . 
URTICARIA . 
Variable Modell Model2.·· Model3 
. · .. 
. 
N~ 1683 1683 1508 
Age 
<25-34 1.00 1.00 1.00 
35-44 0.34 0.35 0.33 
(0.10-1.16) (0.09-1.28) (0.09-1.26) 
45-54 0.67 0.71 0.67 
(0.25-1.82) (0.21-2.39) (0.19-2.31) 
55-65+ 
- -
-
Gender 
Female 1.98 2.01 1.77 
(0.58-6 82) (0.59-6.93) (0.48-6.45) 
Male 1.00 1.00 1.00 
Race/Ethnicity 
Other 1.47 1.48 1.36 
(0.18-11.62) (0.18-11.97) (0.16-1 1.33) 
Black 1.27 1.29 1.06 
(0.51-3 .20) (0.51-3.28) (0.34-3.34) 
White 1.00 1.00 1.00 
Number of years as 
HCW 
<6 year 1.00 1.00 
7~14years 1.78 1.79 
(0.59-5.33) (0.58-5.49) 
15-22 years 0.57 0.62 
(0.10-3.28) (0.11-3.60) 
>23 years 1.19 1.17 
(0.23-6.16) (0.22- 6.31) 
Occupational 
Description 
All Other- 3.93 
Clinical/Prof (0.39-39.98) 
Clinical Lab 2.51 
Tech/Supv (0.24-26.02) 
Faculty 2.00 
(0.19-20.82) 
House Staff -
Housekeeping 3.86 
Staff7Supv (0.57-26.15) 
Nursing Inpatient 2.97 
(0.70-12.62) 
Nursing Inpatient- -
Adrnin/Manager 
Nursing, Admin & 1.23 
Ambul Care (0.12-12.50) 
Office Support- 4.79 
Medical (0.99-23.10) 
Phlebotomist/Tech/ -
Supv 
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Physical- -
OccupTherapy 
Tech/Supv 
Physician's 
-
Assistant/ Associate 
Radiology & Imaging 3.06 
Tech/Staff!Supv (0.30-30.81) 
Respiratory Care 
-
Tech/Supv 
Service, Nursing Care -
Other 1.00 
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Figure I: Identification of study participants 
DUHS healthcare workers in 
DHSSS 
N=25690 
New and existing DUHS health care workers 
completing latex use survey in 2002 and 
2003 
N=4584 
New=951 
Existing= 3633 
DUHS healthcare workers with at least 
two years of health insurance from in 
2002 and 2003 
N=2119 
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Appendix A: 
Disease outcomes potentially related to latex exposure: ICD-9 diagnostic 
codes 
ACUTE CONJUNCTNITIS 
37200 ACUTE CONJUNCTIVITIS NOS 
37201 SEROUS CONJUNCTNITIS CONJUNCTNITIS 
37202 AC FOLLIC CONJUNCTIVITIS CONJUNCTNITIS 
37203 MUCOPUR CONJUNCTNIT NEC CONJUNCTNITIS 
37204 PSEUDOMEMB CONJUNCTNIT CONJUNCTNITIS 
37205 AC ATOPIC CONJUNCTIVITIS CONJUNCTIVITIS 
3721 CHRONIC CONJUNCTNITIS CONJUNCTNITIS 
37210 CHR CONJUNCTIVITIS NOS CONJUNCTNITIS 
37211 SIMPL CHR CONJUNCTIVITIS CONJUNCTNITIS 
37212 CHR FOLLIC CONJUNCTNIT CONJUNCTNITIS 
37213 VERNAL CONJUNCTNITIS CONJUNCTNITIS 
37214 CHR ALLRG CONJUNCTN NEC CONJUNCTNITIS 
3722 BLEPHAROCONJUNCTIVITIS CONJUNCTNITIS 
37220 BLEPHAROCONJUNCTIVIT NOS CONJUNCTNITIS 
ANGULAR 
37221 BLEPHAROCONJUNCT CONJUNCTNITIS 
CONTACT 
37222 BLEPHAROCONJUNCT CONJUNCTNITIS 
3723 CONJUNCTNITIS NEC/NOS CONJUNCTIVITIS 
37230 CONJUNCTNITIS NOS CONJUNCTNITIS 
37231 ROSACEA CONJUNCTNITIS CONJUNCTNITIS 
37233 MUCOCUTAN DIS CONJUNCTN CONJUNCTNITIS 
37239 CONJUNCTNITIS NEC CONJUNCTNITIS 
477 ALLERGIC RHINITIS RHINITIS 
4771 ALLERGIC RHINITIS-FOOD RHINITIS 
4770 RHINITIS DUE TO POLLEN RHINITIS 
4778 ALLERGIC RHINITIS NEC RHINITIS 
4779 ALLERGIC RHINITIS NOS RHINITIS 
493 ASTHMA ASTHMA 
4930 EXTRINSIC ASTHMA ASTHMA 
49300 EXT ASTHMA W/0 STAT ASTH ASTHMA 
49301 EXT ASTHMA W STATUS ASTH ASTHMA 
49302 EXT ASTHMA W ACUTE EXAC ASTHMA 
4931 INTRINSIC ASTHMA ASTHMA 
49310 INT ASTHMA W/0 STAT ASTH ASTHMA 
49311 INT ASTHMA W STATUS ASTH ASTHMA 
49312 INT ASTHMA W ACUTE EXAC ASTHMA 
49320 CH OB ASTH W/0 STAT ASTH ASTHMA 
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49321 CH OB ASTHMA W STAT ASTH ASTHMA 
49322 CH OBS ASTH W ACUTE EXAC ASTHMA 
4939 ASTHMA NOS ASTHMA 
49390 ASTHMA W/0 STATUS ASTHM ASTHMA 
49391 ASTHMA W STATUS ASTHMAT ASTHMA 
ASTHMA W ACUTE 
49392 EXACERBTN ASTHMA 
691 ATOPIC DERMATITIS DERMATITIS 
6910 DIAPER OR NAPKIN RASH DERMATITIS 
6918 OTHER ATOPIC DERMATITIS DERMATITIS 
692 CONTACT DERMATITIS DERMATITIS 
6920 DETERGENT DERMATITIS DERMATITIS 
6921 OIL & GREASE DERMATITIS DERMATITIS 
6922 SOLVENT DERMATITIS DERMATITIS 
6923 TOPICAL MED DERMATITIS DERMATITIS 
6924 CHEMICAL DERMATITIS NEC DERMATITIS 
6925 TOPICAL FOOD DERMATITIS DERMATITIS 
6926 DERMATITIS DUE TO PLANT DERMATITIS 
6927 SOLAR RADIATION DERMAT DERMATITIS 
69270 SOLAR DERMATITIS NOS DERMATITIS 
69271 SUNBURN DERMATITIS 
69272 ACT DRMTITIS SOLAR RDIAT DERMATITIS 
69273 ACTNC RETIC ACTNC GRNLMA DERMATITIS 
69274 OTH CHR DRMTIT SOLAR RAD DERMATITIS 
69275 DIS SUP ACTNC POROKRTSIS DERMATITIS 
69279 OTH DERMATITIS SOLAR RAD DERMATITIS 
6928 OTHER DERMATITIS DERMATITIS 
69281 COSMETIC DERMATITIS DERMATITIS 
69282 DERMATITIS OTH RADIATION DERMATITIS 
69283 DERMATITIS METALS DERMATITIS 
69289 DERMATITIS NEC DERMATITIS 
6929 DERMATITIS NOS DERMATITIS 
693 DERMAT D/T INTERN AGENT DERMATITIS 
708 URTICARIA URTICARIA 
7080 ALLERGIC URTICARIA URTICARIA 
7081 IDIOPATHIC URTICARIA URTICARIA 
7082 URTICARIA FROM COLD/HEAT URTICARIA 
DERMATOGRAPHIC 
7083 URTICARIA URTICARIA 
7084 VIBRATORY URTICARIA URTICARIA 
7085 CHOLINERGIC URTICARIA URTICARIA 
7088 URTICARIA NEC URTICARIA 
7089 URTICARIA NOS URTICARIA 
782 SKIN/OTH INTEGUMENT SYMP SKIN 
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7820 SKIN SENSATION DISTURB SKIN 
7821 NONSPECIF SKIN ERUPT NEC SKIN 
7822 LOCAL SUPRFICIAL SWELLNG SKIN 
78602 ORTHOPNEA LUNG 
78603 APNEA LUNG 
78604 CHEYNE-STOKES RESPIRATN LUNG 
78605 SHORTNESS OF BREATH LUNG 
78606 TACHYPNEA LUNG 
78607 WHEEZING LUNG 
78609 RESPIRATORY ABNORM NEC LUNG 
7861 STRIDOR LUNG 
7862 COUGH LUNG 
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